Residues of animal drugs with carcinogenic potential cannot always be avoided in food. The risk/benefit evaluation of carcinogenic drugs used in food‐producing animals is a scientifically unresolved problem. Nonetheless, a pragmatic solution taking into account such drugs’ putative mechanisms of action, their relative potency, and their significance in the prevention and therapy of disease must and can be achieved.